Blended vs Conventional Training for ACLS

June 25, 2026 updated by: Min Ding, Shanghai East Hospital of Tongji University

Blended Learning Approach Versus Conventional Training in Advanced Cardiovascular Life Support Training: A Randomized Controlled Trial With Cost-Effectiveness Analysis

The investigators conducted a stratified randomized controlled trial with an embedded cost-effectiveness analysis at a tertiary hospital in China. Participants were randomized to either traditional instructor-led ACLS training (ILT ACLS) or blended-learning HeartCode ACLS training (HC ACLS). The primary outcome was the overall first-attempt ACLS certification pass rate. A cost-effectiveness analysis was conducted from the institutional perspective using certification pass rate as the effectiveness measure. Costs estimation included program delivery costs and productivity losses associated with participant training time.

Study Overview

Study Type

Interventional

Enrollment (Actual)

95

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200120
        • Shanghai East Hospital Affiliated To Tongji University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Second-year resident physicians and nurses
  • Working in the emergency, critical care, or anesthesiology departments
  • Valid Basic Life Support (BLS) certification
  • No prior Advanced Cardiovascular Life Support (ACLS) training
  • Physical ability to perform chest compressions, bag-mask ventilation, and defibrillation
  • Willing and able to provide written informed consent

Exclusion Criteria:

  • Individuals without a valid BLS certification

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HeartCode ACLS
Participants received blended-learning HeartCode ACLS training, which combines online self-paced modules with hands-on practice sessions.
A blended-learning ACLS course combining online HeartCode self-paced modules with instructor-facilitated hands-on practice sessions.
Active Comparator: Instructor-Led ACLS Training
Participants received traditional instructor-led ACLS training (ILT ACLS) delivered entirely in-person by certified instructors.
A traditional, entirely in-person ACLS course delivered by certified instructors, following standard American Heart Association (AHA) guidelines, without online pre-learning components.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall First-Attempt ACLS Certification Pass Rate
Time Frame: Up to 2 days.
The proportion of participants who pass the ACLS certification examination on their first attempt after completing the assigned training program.
Up to 2 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First-Attempt Pass Rate for Individual Assessments
Time Frame: Up to 2 days.
Proportion of participants who pass each of the three individual assessments (high-quality BLS, airway management, and Megacode) on the first attempt.
Up to 2 days.
CPR Quality - Compression Depth
Time Frame: Up to 2 days.
Mean chest compression depth (mm) recorded during Megacode assessment, measured by high-fidelity manikin with QCPR technology.
Up to 2 days.
CPR Quality - Compression Rate
Time Frame: Up to 2 days.
Mean chest compression rate (compressions per minute) recorded during Megacode assessment.
Up to 2 days.
CPR Quality - Chest Recoil
Time Frame: Up to 2 days.
Proportion of compressions with adequate chest recoil (percentage) recorded during Megacode assessment.
Up to 2 days.
Training Cost per Participant
Time Frame: Through study completion, an average of 6 months.
Mean total training cost per participant (in RMB), including program delivery costs (equipment, facilities, materials, personnel) and productivity losses.
Through study completion, an average of 6 months.
Participant Satisfaction
Time Frame: Up to 2 days.
Learner satisfaction measured using the AHA ACLS Classroom Course Evaluation Form, completed immediately after course completion.
Up to 2 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Min Ding, MMED, Department of Post-Graduate Education, Shanghai East Hospital, Tongji University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

June 16, 2026

First Submitted That Met QC Criteria

June 25, 2026

First Posted (Actual)

June 26, 2026

Study Record Updates

Last Update Posted (Actual)

June 26, 2026

Last Update Submitted That Met QC Criteria

June 25, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024YS-296
  • 2026-0345-YB-05 (Other Grant/Funding Number: Tongji University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared because the informed consent did not include provisions for data sharing. Additionally, data sharing is restricted by applicable Chinese privacy laws (Personal Information Protection Law) regarding personal performance data. Given the single-center design and moderate sample size, the generalizability of the data is limited, and the study does not involve investigational products or regulatory submission.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cardiovascular Life Support

Clinical Trials on HeartCode ACLS Blended Learning

Subscribe